Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement
The treatment of aortic stenosis has evolved in recent years with the introduction of transcatheter aortic valve replacement (TAVR) as a complementary strategy to surgical aortic valve replacement (SAVR). The majority of clinical trials to date have included only tricuspid aortic stenosis and exclud...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2022-08-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2021.32 |
| _version_ | 1826933206550577152 |
|---|---|
| author | Arthur J Lee Imran Baig Katherine B Harrington Molly Szerlip |
| author_facet | Arthur J Lee Imran Baig Katherine B Harrington Molly Szerlip |
| author_sort | Arthur J Lee |
| collection | DOAJ |
| description | The treatment of aortic stenosis has evolved in recent years with the introduction of transcatheter aortic valve replacement (TAVR) as a complementary strategy to surgical aortic valve replacement (SAVR). The majority of clinical trials to date have included only tricuspid aortic stenosis and excluded bicuspid aortic valves (BAVs). BAVs are associated with unique challenges related to their anatomy, clinical presentation, and association with aortopathy. BAV has a spectrum of phenotypes and the classification is still evolving. There have been no definitive clinical guidelines on triaging BAV patients towards TAVR or SAVR. Given that TAVR is moving from high-risk to low-risk patients and becoming more widely used in the treatment of BAV, there are many factors that must be considered. The aim of this article is to review the literature and present considerations for heart teams to discuss in order to offer patients the best lifetime management strategy for BAV stenosis. |
| first_indexed | 2024-03-07T17:40:09Z |
| format | Article |
| id | doaj.art-a3a44ceacdc246f3a9e821cf78274b58 |
| institution | Directory Open Access Journal |
| issn | 1758-3896 1758-390X |
| language | English |
| last_indexed | 2025-02-17T17:28:22Z |
| publishDate | 2022-08-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | US Cardiology Review |
| spelling | doaj.art-a3a44ceacdc246f3a9e821cf78274b582024-12-14T16:03:50ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2022-08-011610.15420/usc.2021.32Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve ReplacementArthur J Lee0Imran Baig1Katherine B Harrington2Molly Szerlip3Baylor Scott and White Heart, The Heart Hospital Plano, Plano, TXBaylor Scott and White Heart, The Heart Hospital Plano, Plano, TXBaylor Scott and White Heart, The Heart Hospital Plano, Plano, TXBaylor Scott and White Heart, The Heart Hospital Plano, Plano, TXThe treatment of aortic stenosis has evolved in recent years with the introduction of transcatheter aortic valve replacement (TAVR) as a complementary strategy to surgical aortic valve replacement (SAVR). The majority of clinical trials to date have included only tricuspid aortic stenosis and excluded bicuspid aortic valves (BAVs). BAVs are associated with unique challenges related to their anatomy, clinical presentation, and association with aortopathy. BAV has a spectrum of phenotypes and the classification is still evolving. There have been no definitive clinical guidelines on triaging BAV patients towards TAVR or SAVR. Given that TAVR is moving from high-risk to low-risk patients and becoming more widely used in the treatment of BAV, there are many factors that must be considered. The aim of this article is to review the literature and present considerations for heart teams to discuss in order to offer patients the best lifetime management strategy for BAV stenosis.https://www.uscjournal.com/articleindex/usc.2021.32 |
| spellingShingle | Arthur J Lee Imran Baig Katherine B Harrington Molly Szerlip Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement US Cardiology Review |
| title | Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement |
| title_full | Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement |
| title_fullStr | Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement |
| title_full_unstemmed | Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement |
| title_short | Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement |
| title_sort | bicuspid aortic stenosis with and without aortopathy considerations for surgical aortic valve replacement versus transcatheter aortic valve replacement |
| url | https://www.uscjournal.com/articleindex/usc.2021.32 |
| work_keys_str_mv | AT arthurjlee bicuspidaorticstenosiswithandwithoutaortopathyconsiderationsforsurgicalaorticvalvereplacementversustranscatheteraorticvalvereplacement AT imranbaig bicuspidaorticstenosiswithandwithoutaortopathyconsiderationsforsurgicalaorticvalvereplacementversustranscatheteraorticvalvereplacement AT katherinebharrington bicuspidaorticstenosiswithandwithoutaortopathyconsiderationsforsurgicalaorticvalvereplacementversustranscatheteraorticvalvereplacement AT mollyszerlip bicuspidaorticstenosiswithandwithoutaortopathyconsiderationsforsurgicalaorticvalvereplacementversustranscatheteraorticvalvereplacement |